Yuta Takashima

Sapporo, 0600815, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Severe psoriasis as an immune-related adverse event after long-term atezolizumab therapy for pulmonary large-cell neuroendocrine carcinoma: A case report.

Severe psoriasis as an immune-related adverse event after long-term atezolizumab therapy for pulmonary large-cell neuroendocrine carcinoma: A case report.

Journal: Respiratory medicine case reports

Published: February 27, 2026

Clinical characteristics of long-term survivors of small cell lung cancer.

Clinical characteristics of long-term survivors of small cell lung cancer.

Journal: Respiratory investigation

Published: February 05, 2026

Comparison of anthracycline plus platinum versus other platinum-based regimens as first-line chemotherapy for untreated thymoma: A retrospective cohort study (NEJ023B).

Comparison of anthracycline plus platinum versus other platinum-based regimens as first-line chemotherapy for untreated thymoma: A retrospective cohort study (NEJ023B).

Journal: Lung cancer (Amsterdam, Netherlands)

Published: January 29, 2026

A case of synchronous multiple primary lung cancers each harboring an EGFR mutation or an ALK fusion gene alone that responded to osimertinib with chemotherapy.

A case of synchronous multiple primary lung cancers each harboring an EGFR mutation or an ALK fusion gene alone that responded to osimertinib with chemotherapy.

Journal: Respiratory investigation

Published: October 27, 2025

Amivantamab-Associated Vasculitis in a Patient With EGFR Exon 20 Insertion Non-Small Cell Lung Cancer: A Case Report.

Amivantamab-Associated Vasculitis in a Patient With EGFR Exon 20 Insertion Non-Small Cell Lung Cancer: A Case Report.

Journal: Clinical lung cancer

Published: October 23, 2025

Limited-Stage Small-Cell Lung Cancer With Severe Paraneoplastic Limbic Encephalitis Successfully Treated With Chemoradiotherapy Followed by Immune Checkpoint Inhibitor Maintenance Therapy: A Case Report.

Limited-Stage Small-Cell Lung Cancer With Severe Paraneoplastic Limbic Encephalitis Successfully Treated With Chemoradiotherapy Followed by Immune Checkpoint Inhibitor Maintenance Therapy: A Case Report.

Journal: Clinical lung cancer

Published: October 12, 2025

Successful treatment of huntingtin-interacting protein-1-anaplastic lymphoma kinase-positive lung cancer with severe airway stenosis using silicone stent placement and alectinib.

Successful treatment of huntingtin-interacting protein-1-anaplastic lymphoma kinase-positive lung cancer with severe airway stenosis using silicone stent placement and alectinib.

Journal: Respiratory investigation

Published: July 25, 2025

Frequency and Prognostic Impact of Local Ablation Therapy for Oligoprogression in Non-Small Cell Lung Cancer.

Frequency and Prognostic Impact of Local Ablation Therapy for Oligoprogression in Non-Small Cell Lung Cancer.

Journal: Thoracic cancer

Published: April 28, 2025

Prospective multicenter validation of a next-generation sequencing panel using cytology specimens for lung cancer: cPANEL.

Prospective multicenter validation of a next-generation sequencing panel using cytology specimens for lung cancer: cPANEL.

Journal: BMC cancer

Published: April 08, 2025

Efficacy and safety of lenvatinib in a case of thymic carcinoma complicated with interstitial lung disease and anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: A case report.

Efficacy and safety of lenvatinib in a case of thymic carcinoma complicated with interstitial lung disease and anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: A case report.

Journal: Respiratory medicine case reports

Published: February 12, 2025

Evaluating the Efficacy of Thin Convex-probe Endobronchial Ultrasound Bronchoscope in Cadaveric Models.

Evaluating the Efficacy of Thin Convex-probe Endobronchial Ultrasound Bronchoscope in Cadaveric Models.

Journal: Journal of bronchology & interventional pulmonology

Published: October 17, 2024

Remarkable response to low dose of selpercatinib in a patient with RET-rearranged non-small cell lung cancer.

Remarkable response to low dose of selpercatinib in a patient with RET-rearranged non-small cell lung cancer.

Journal: Respiratory medicine case reports

Published: October 07, 2024

Showing 1-12 of 26

Last Updated: 09/26/2026